SCHEMBL167930

SCHEMBL167930

[CH2]CCCCC(C(=O)O)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TBXAS1 P24557 1/20 0.36
GSR P00390 1/20 0.36
ENPEP Q07075 1/20 0.36
GPR84 Q9NQS5 3/20 0.34
RNPEP Q9H4A4 1/20 0.34
FFAR1 O14842 1/20 0.34
MAPT P10636 1/20 0.33
LCK P06239 1/20 0.33
PPARD Q03181 1/20 0.33
ZDHHC20 Q5W0Z9 1/20 0.33
ZDHHC2 Q9UIJ5 1/20 0.33
ARG2 P78540 4/20 0.32
ARG1 P05089 3/20 0.32
ACE2 Q9BYF1 1/20 0.31
FOLH1 Q04609 1/20 0.31
CPB2 Q96IY4 1/20 0.31
CYP1A2 P05177 1/20 0.31
GLA P06280 1/20 0.31
TSHR P16473 1/20 0.31
NFKB1 P19838 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL168927 0.97 TBXAS1 (0.39) TBXAS1GSRENPEPGPR84RNPEP
SCHEMBL27574099 0.97 TBXAS1 (0.39) TBXAS1GSRENPEPGPR84RNPEP
SCHEMBL168046 0.97 TBXAS1 (0.39) TBXAS1GSRENPEPGPR84RNPEP
SCHEMBL27856541 0.97 TBXAS1 (0.39) TBXAS1GSRENPEPGPR84RNPEP
SCHEMBL165661 0.97 TBXAS1 (0.39) TBXAS1GSRENPEPGPR84RNPEP
SCHEMBL168355 0.97 TBXAS1 (0.39) TBXAS1GSRENPEPGPR84RNPEP
SCHEMBL165787 0.92 ENPEP (0.37) TBXAS1GSRENPEPGPR84RNPEP
SCHEMBL12851496 0.85 GSR (0.43) TBXAS1GSRENPEPGPR84RNPEP
SCHEMBL21073899 0.82 GPR84 (0.46) TBXAS1GSRENPEPGPR84RNPEP
SCHEMBL30018584 0.82 GPR84 (0.46) TBXAS1GSRENPEPGPR84RNPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4381345-A1 SWITCHING LAYERS FOR USE IN A WINDOW ELEMENT Merck Patent GmbH (DE) 2024-06-12 EP disclosed
EP-3704176-B1 ORGANIC SEMICONDUCTING COMPOUNDS RAYNERGY TEK INC (TW) 2024-05-15 EP disclosed
US-20240134218-A1 DEVICE FOR THE REGULATION OF LIGHT TRANSMISSION MERCK PATENT GMBH (DE) 2024-04-25 US disclosed
US-11958819-B2 Compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2024-04-16 US disclosed
US-11952528-B2 Switching layers for use in a switching element MERCK PATENT GMBH (DE) 2024-04-09 US disclosed
CN-111433323-B Liquid-crystalline medium for switching elements 默克专利股份有限公司 2024-03-22 CN disclosed
CN-113544186-B Organic semiconductor composition 天光材料科技股份有限公司 2024-03-19 CN disclosed
EP-3794650-B1 ORGANIC SEMICONDUCTORS RAYNERGY TEK INC (TW) 2024-03-13 EP disclosed
CN-112424966-B organic semiconductor 天光材料科技股份有限公司 2023-12-26 CN disclosed
US-11839155-B2 Organic semiconducting compounds RAYNERGY TEK INC. (TW) 2023-12-05 US disclosed
WO-1991008184-A2 1,2-DISUBSTITUTED 2,6-DIFLUOROBENZENE COMPOUNDS AND LIQUID CRYSTAL MEDIA MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1991-06-13 WO disclosed
EP-0418362-A1 TRIFLUOROMETHYLCYCLOHEXANE DERIVATIVES. MERCK PATENT GMBH (DE) 1991-03-27 EP disclosed
WO-1990012073-A1 TRIFLUOROMETHYLCYCLOHEXANE DERIVATIVES MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1990-10-18 WO disclosed
EP-0381728-A1 DIFLUOROMETHYL COMPOUNDS. MERCK PATENT GMBH (DE) 1990-08-16 EP disclosed
EP-0367771-A1 ARYL SULPHUR PENTAFLUORIDES. MERCK PATENT GMBH (DE) 1990-05-16 EP disclosed
US-4925590-A Derivatives of 4-cyano-2,3-difluorophenol MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1990-05-15 US disclosed
WO-1990001056-A1 DIFLUOROMETHYL COMPOUNDS MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1990-02-08 WO disclosed
EP-0329752-A1 FLUORINATED OLIGOPHENYLS AND THEIR USE IN LIQUID CRYSTAL MATERIALS MERCK PATENT GmbH (DE) 1989-08-30 EP disclosed
WO-1989002425-A1 FLUORINATED OLIGOPHENYLS AND THEIR USE IN LIQUID CRYSTAL MATERIALS MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1989-03-23 WO disclosed
WO-1988010251-A1 ARYL SULPHUR PENTAFLUORIDES MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1988-12-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11839155-B2 Organic semiconducting compounds OCIAD2, OCIAD1, OSTC TBXAS1 1437/4885GSR 3686/4885ENPEP 4567/4885
US-11958819-B2 Compounds for optically active devices PDE6C, ALDH1A2, PDE6A TBXAS1 678/4885GSR 3666/4885ENPEP 844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.